中文版 | Favorite | SethomePage
Position: home>Products>>Monoclonal Antibody

 
 

 
 
Monoclonal Antibody
Name:Eculizumab biosimilar
Purchase
Description

Eculizumab biosimilar is a recombinant humanized monoclonal IgG2/4κ antibody produced by Chinese hamster ovary cell culture and purified by standard bioprocess technology. Eculizumab biosimilar contains human constant regions from human IgG2 sequences and human IgG4 sequences and murine complementarity-determining regions grafted onto the human framework light- and heavy-chain variable regions. Eculiz umab biosimilaris composed of two 448 amino acid heavy chains and two 214 amino acid light chains and has a molecular weight of approximately 148 kDa.


Eculizumab biosimilar is supplied at a concentration of 10 mg/mL as a sterile, preservative-free, clear, colorless solution of pH 7.0, which contains 0.46 mg/mL sodium phosphate monobasic, 1.78 mg/mL sodium phosphate dibasic, 8.77 mg/mL sodium chloride, 0.22 mg/mL polysorbate 80 (vegetable origin).

Statement: this product is used for R&D only, not for clinical usage.

Properties

Name

Eculizumab biosimilar

CAS NO.

219685-50-4

Type

Whole antibody

Source

Humanized (from mouse)

Target

Complement protein C5

Clone

Monoclone

Molecular Weight

148 kDa

Antibody Form

Purified immunoglobulin

Physical Form

Solution

Grade Standard

Medicine Grade

Place of Origin

China (Mainland)

Storage

-70±15 for long-term storage, 2-8 for short-term storage, away from light.

Supply Ability
20 kilogram per year, Minimum order quantity is 1 gram.
Price
Inquiry
Material Safety Data Sheet
If you need more information, please contact us.
Certificate Of Analysis

/en/UploadFile/file/201805/2018050815400243243.rar





Detail information about the product please refer the website below:

https://en.wikipedia.org/wiki/Eculizumab



hits:1835
 


Add:133# Dongzheng Road Pudong Disrict, Shanghai, China
Copyright © Shanghai TheraMabs Bio-technology co., LTD  ICP88888888  Powered By dotodo.net